Vital Therapies reported $4.12M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Dynavax Technologies DVAX:US $ 4.96M 15.24M
Enanta Pharmaceuticals ENTA:US $ 1.25M 4.74M
Epizyme EPZM:US $ 5M 2.91M
Insmed INSM:US $ 31.14M 17.43M
Intercept Pharmaceuticals ICPT:US $ 11.67M 1.28M
Mirati Therapeutics MRTX:US $ 24.27M 3.67M
Omeros OMER:US $ 10.88M 3.53M
Orasure Technologies OSUR:US $ 36.23M 9.17M
Quidel QDEL:US $ 247.3M 89.83M
Regulus Therapeutics RGLS:US $ 0.6M 0.03M
Revance Therapeutics RVNC:US $ 13.27M 3.25M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
Vital Therapies VTL:US $ 4.12M 0.83M
Xoma XOMA:US $ 1.15M 366K